Asia Pacific Enzyme Replacement Therapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Enzyme Type (Alglucosidase Alfa, Agalsidase Beta, Imiglucerase, Idursulfase, Galsulfase, Velaglucerase Alfa, and Other Enzymes), Therapeutic Conditions (Gaucher's Disease, Fabry's Disease, MPS, Pompe's Disease, SCID, and Other Therapeutic Conditions), Route of Administration (Parenteral and Oral), and End User (Hospitals, Infusion Centers, and Others)
The enzyme replacement therapy market in Asia Pacific is expected to grow from US$ 2,415.74 million in 2022 to US$ 3,783.02 million by 2028. It is estimated to grow at a CAGR of 7.8% from 2022 to 2028.
Innovative Developments in Enzyme Replacement Therapy
Enzyme replacement therapy administration typically requires 1–2 hours and is repeated monthly. Infusions are usually administered at infusion centers; however, under certain conditions, they can be administered at home by a nurse. Enzyme testing is usually the initial diagnostic test, but genetic analysis of gene mutations adds precision. For instance, small-molecule therapies, including substrate reduction and chaperone therapies, have also been developed and are approved for a few lysosomal storage diseases (LSDs). Additionally, companies are working to develop new therapies at the genomic level. For instance, SmartPharm is working to replace the administration of recombinant proteins by introducing the gene into the body to make the protein available over a long period. Successful gene-encoded therapeutics are expected to prolong the period between treatments. It could eliminate the infrastructure of infusion now required to deliver these proteins, thus freeing the patients from burdens related to current enzyme replacement therapy administration. Therefore, the trend of combining gene therapy with enzyme replacement therapy is expected to grow during the forecast period.
Market Overview
The enzyme replacement therapy market in Asia Pacific is segmented into Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific. The APAC enzyme replacement therapy market in Japan is growing due to robust research and increasing ERT product approvals. For instance, in March 2022, Sanofi announced that the Japanese Ministry of Health, Labor, and Welfare (MHLW) granted marketing authorization for Xenpozyme (olipudase alfa) for the treatment of acid sphingomyelinase deficiency (ASMD). Also, Xenpozyme is the first and only approved therapy in Japan indicated to treat acid sphingomyelinase deficiency. Moreover, Japan's technologically advanced environment helps companies develop new products. For instance, in March 2021, JCR Pharmaceuticals announced the approval of IZCARGO (Pabinafusp Alfa) to treat Hunter syndrome. Thus, technological advancement and rising drug approvals are expected to fuel the enzyme replacement therapy market in Japan during the forecast period.
Asia Pacific Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)
Get more information on this report :
Asia Pacific Enzyme Replacement Therapy Market Segmentation
The Asia Pacific enzyme replacement therapy market is segmented into enzyme type, therapeutic conditions, route of administration, end user, and country.
- Based on enzyme type, the Asia Pacific enzyme replacement therapy market is segmented into alglucosidase alfa, agalsidase beta, imiglucerase, idursulfase, galsulfase, velaglucerase alfa, and other enzymes. The other enzymes segment registered the largest market share in 2022.
By therapeutic conditions, the Asia Pacific enzyme replacement therapy market is segmented into Gaucher's disease, Fabry's disease, MPS, Pompe's disease, SCID, and other therapeutic conditions. The Gaucher's disease segment held the largest market share in 2022.
In terms of route of administration, the Asia Pacific enzyme replacement therapy market is bifurcated into parenteral and oral. The parenteral segment held a larger market share in 2022.
From end user point of reference, the Asia Pacific enzyme replacement therapy market is segmented into hospitals, infusion centers, and others. The hospitals segment held the largest market share in 2022.
- Based on country, the Asia Pacific enzyme replacement therapy market is segmented into Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific. Japan dominated the market in 2022.
Sanofi; BioMarine Pharmaceutical Inc; Takeda Pharmaceutical Company Limited; AbbVie Inc; Janssen Pharmaceutical (Johnson & Johnson Services, Inc.); Alexion Pharmaceutical, Inc. (AstaZeneca); Amicus Therapeutics; Recordati S.p.A; Recordati S.p.A; CHIESI farmaceutici S.p.A; and Pfizer Inc are the leading companies operating in the enzyme replacement therapy market in Asia Pacific.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Enzyme Replacement Therapy Market – By Enzyme Type
1.3.2 APAC Enzyme Replacement Therapy Market – By Therapeutic Conditions
1.3.3 APAC Enzyme Replacement Therapy Market – By Route of Administration
1.3.4 APAC Enzyme Replacement Therapy Market – By End User
1.3.5 APAC Enzyme Replacement Therapy Market – By Country
2. APAC Enzyme Replacement Therapy Market– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Enzyme Replacement Therapy Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific – PEST Analysis
4.3 Expert Opinion
5. APAC Enzyme Replacement Therapy Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Lysosomal Storage Diseases (LSDs)
5.1.2 Rapid Regulatory Approval with Other Benefits for Drug with Orphan Drug Designation
5.2 Market Restraints
5.2.1 Cutthroat Competition among Market Players
5.3 Market Opportunities
5.3.1 Increasing Partnerships and Collaborations to Synergize the Business
5.4 Future Trends
5.4.1 Innovative Developments in ERT
5.5 Impact Analysis
6. Enzyme Replacement Therapy Market– APAC Analysis
6.1 APAC Enzyme Replacement Therapy Market Revenue Forecast and Analysis
7. APAC Enzyme Replacement Therapy Market Revenue and Forecasts To 2028– by Enzyme Type
7.1 Overview
7.2 APAC Enzyme Replacement Therapy Market, By Enzyme Type 2021 & 2028 (%)
7.3 Alglucosidase Alfa
7.3.1 Overview
7.3.2 Alglucosidase Alfa Revenue and Forecast to 2028 (US$ Million)
7.4 Agalsidase Beta
7.4.1 Overview
7.4.2 Agalsidase Beta - Revenue and Forecast to 2028 (US$ Million)
7.5 Imiglucerase
7.5.1 Overview
7.5.2 Imigluceras - Revenue and Forecast to 2028 (US$ Million)
7.6 Idursulfase
7.6.1 Overview
7.6.2 Idursulfase - Revenue and Forecast to 2028 (US$ Million)
7.7 Galsulfase
7.7.1 Overview
7.7.2 Galsulfase - Revenue and Forecast to 2028 (US$ Million)
7.8 Velaglucerase Alfa
7.8.1 Overview
7.8.2 Velaglucerase Alfa - Revenue and Forecast to 2028 (US$ Million)
7.9 Other Enzymes
7.9.1 Overview
7.9.2 Other Enzymes - Revenue and Forecast to 2028 (US$ Million)
8. APAC Enzyme Replacement Therapy Market Analysis and Forecasts To 2028 – By Therapeutic Conditions
8.1 Overview
8.2 APAC Enzyme Replacement Therapy Market, By Therapeutic Conditions 2021 & 2028 (%)
8.3 Gaucher's Disease
8.3.1 Overview
8.3.2 Gaucher's Disease - Market Revenue and Forecast to 2028 (US$ Million)
8.4 Fabry's Disease
8.4.1 Overview
8.4.2 Fabry's Disease - Market Revenue and Forecast to 2028 (US$ Million)
8.5 Mucopolysaccharidosis (MPS)
8.5.1 Overview
8.5.2 MPS - Market Revenue and Forecast to 2028 (US$ Million)
8.6 Pompe's Disease
8.6.1 Overview
8.6.2 Pompe's Disease - Market Revenue and Forecast to 2028 (US$ Million)
8.7 SCID
8.7.1 Overview
8.7.2 SCID - Market Revenue and Forecast to 2028 (US$ Million)
8.8 Other Therapeutic Conditions
8.8.1 Overview
8.8.2 Other Therapeutic Conditions - Market Revenue and Forecast to 2028 (US$ Million)
9. APAC Enzyme Replacement Therapy Market Analysis and Forecasts To 2028 – By Route of Administration
9.1 Overview
9.2 APAC Enzyme Replacement Therapy Market, By Route of Administration 2021 & 2028 (%)
9.3 Parenteral
9.3.1 Overview
9.3.2 Parenteral - Market Revenue and Forecast to 2028 (US$ Million)
9.4 Oral
9.4.1 Overview
9.4.2 Oral - Market Revenue and Forecast to 2028 (US$ Million)
10. APAC Enzyme Replacement Therapy Market Analysis– By End User
10.1 Overview
10.2 APAC Enzyme Replacement Therapy Market, By End User 2021 & 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals - Market Revenue and Forecasts To 2028 (US$ Million)
10.4 Infusion Centers
10.4.1 Overview
10.4.2 Infusion Centers - Market Revenue and Forecasts To 2028 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others - Market Revenue and Forecasts To 2028 (US$ Million)
11. APAC Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 – Country Analysis
11.1 Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts To 2028
11.1.1 Overview
11.1.2 Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Country (%)
11.1.2.1 Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
11.1.2.1.1 Overview
11.1.2.1.2 Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
11.1.2.1.3 Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
11.1.2.1.4 Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
11.1.2.1.5 Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
11.1.2.1.6 Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.1.2.2 China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
11.1.2.2.1 Overview
11.1.2.2.2 China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
11.1.2.2.3 China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
11.1.2.2.4 China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
11.1.2.2.5 China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
11.1.2.2.6 China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.1.2.3 India Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
11.1.2.3.1 Overview
11.1.2.3.2 India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
11.1.2.3.3 India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
11.1.2.3.4 India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
11.1.2.3.5 India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
11.1.2.3.6 India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.1.2.4 Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
11.1.2.4.1 Overview
11.1.2.4.2 Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
11.1.2.4.3 Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
11.1.2.4.4 Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
11.1.2.4.5 Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
11.1.2.4.6 Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.1.2.5 South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
11.1.2.5.1 Overview
11.1.2.5.2 South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
11.1.2.5.3 South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
11.1.2.5.4 South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
11.1.2.5.5 South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
11.1.2.5.6 South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.1.2.6 Rest of Asia Pacific: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.2.6.1 Overview
11.1.2.6.2 Rest of Asia Pacific: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.2.6.3 Rest of Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
11.1.2.6.4 Rest of Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
11.1.2.6.5 Rest of Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
11.1.2.6.6 Rest of Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
12. APAC Enzyme Replacement Therapy Market–Industry Landscape
12.1 Overview
12.2 Inorganic Growth Strategies
12.2.1 Overview
12.3 Organic Growth Strategies
12.3.1 Overview
13. Company Profiles
13.1 Sanofi
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 BioMarin Pharmaceutical Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Takeda Pharmaceutical Company Limited
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 AbbVie Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.)
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Alexion Pharmaceuticals, Inc. (AstraZeneca)
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 WOT Analysis
13.6.6 Key Developments
13.7 Amicus Therapeutics
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Recordati S.p.A.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 CHIESI Farmaceutici S.p.A.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Pfizer Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
Table 2. Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
Table 3. Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 4. Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 5. China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
Table 6. China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
Table 7. China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 8. China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 9. India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
Table 10. India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
Table 11. India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 12. India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 13. Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
Table 14. Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
Table 15. Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 16. Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 17. South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
Table 18. South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
Table 19. South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 20. South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 21. Rest of Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Enzyme Type (US$ Million)
Table 22. Rest of Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Therapeutic Conditions (US$ Million)
Table 23. Rest of Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 24. Rest of Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 25. Recent Inorganic Growth Strategies in the Enzyme Replacement Therapy Market
Table 26. Recent Organic Growth Strategies in the Enzyme Replacement Therapy Market
Table 27. Glossary of Terms
LIST OF FIGURES
Figure 1. APAC Enzyme Replacement Therapy Market Segmentation
Figure 2. APAC Enzyme Replacement Therapy Market Segmentation, By Country
Figure 3. APAC Enzyme Replacement Therapy Market Overview
Figure 4. APAC Enzyme Replacement Therapy Market, By Enzyme Type
Figure 5. APAC Enzyme Replacement Therapy Market, By Country
Figure 7. Asia Pacific: PEST Analysis
Figure 8. Expert Opinion
Figure 9. APAC Impact Analysis
Figure 10. APAC Enzyme Replacement Therapy Market– Revenue Forecast and Analysis – 2020- 2028
Figure 11. APAC Enzyme Replacement Therapy Market, by Enzyme Type 2021 & 2028 (%)
Figure 12. APAC Alglucosidase Alfa Revenue and Forecasts to 2028 (US$ Million)
Figure 13. APAC Agalsidase Beta - Revenue and Forecasts to 2028 (US$ Million)
Figure 14. APAC Imiglucerase - Revenue and Forecasts to 2028 (US$ Million)
Figure 15. APAC Idursulfase - Revenue and Forecasts to 2028 (US$ Million)
Figure 16. APAC Galsulfase - Revenue and Forecasts to 2028 (US$ Million)
Figure 17. APAC Velaglucerase Alfa - Revenue and Forecasts to 2028 (US$ Million)
Figure 18. APAC Other Enzymes - Revenue and Forecasts to 2028 (US$ Million)
Figure 19. APAC Enzyme Replacement Therapy Market, by Therapeutic Conditions 2021 & 2028 (%)
Figure 20. APAC Gaucher's Disease - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. APAC Fabry's Disease - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. APAC MPS - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. APAC Pompe's Disease - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. APAC SCID - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. APAC Other Therapeutic Conditions - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. APAC Enzyme Replacement Therapy Market, by Route of Administration 2021 & 2028 (%)
Figure 27. APAC Parenteral - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. APAC Oral - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. APAC Enzyme Replacement Therapy Market, by End User 2021 & 2028 (%)
Figure 30. APAC Hospitals - Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31. APAC Infusion Centers - Market Revenue and Forecasts To 2028 (US$ Million)
Figure 32. APAC Others- Market Revenue and Forecasts To 2028 (US$ Million)
Figure 33. Asia Pacific: Enzyme Replacement Therapy Market Overview, by Country (2021)
Figure 34. Asia Pacific: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028, By Country (%)
Figure 35. Japan: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 36. China: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 37. India: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 38. Australia: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 39. South Korea: Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 40. Rest of Asia Pacific: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)
- Sanofi.
- BioMarine Pharmaceutical Inc.
- Takeda Pharmaceutical Company Limited.
- AbbVie Inc.
- Janssen Pharmaceutical ( Johnson & Johnson Services,Inc.).
- Alexion Pharmaceutical, Inc.(AstaZeneca).
- Amicus Therapeutics.
- Recordati S.p.A.
- CHIESI farmaceutici S.p.A.
- Pfizer Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific enzyme replacement therapy market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific enzyme replacement therapy market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the enzyme replacement therapy market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution